Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Genome Engineering, Bioinformatics), Applications (Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental)- Global Forecast to 2027

Abstract
The global synthetic biology market size is projected to reach USD 35.7 billion by 2027 from USD 11.4 billion in 2022, at a CAGR of 25.6% during the forecast period. Factors such as increasing investment in synthetic biology research, declining cost of DNA sequencing, increasing adoption of synthetic biology across various industries are driving the market growth at faster pace.

“The oligonucleotides and synthetic DNA segment is likely to grow at highest CAGR during the forecast period of 2022-2027.”

On the basis of tools, the synthetic biology market is segmented into oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids. The oligonucleotides and synthetic DNA segment is projected to grow at highest CAGR during the forecast period. The growth is attributed to increased demand for synthetic DNA, synthetic RNA, and synthetic genes across various industries. Furthermore, launch of novel products in the market is further likely to have positive impact on the segmental growth.

“The gene synthesis segment held dominant share in 2021.”

Based on technology, the market is segmented into gene synthesis, genome engineering, sequencing, bioinformatics, cloning, site-directed mutagenesis, measurement and modeling, microfluidics, nanotechnology. The genome engineering segment is expected to grow at faster pace during the the forecast period due to factors such as the use of these techniques in therapeutics development, advancement in CRISPR technologies is increasing adoption.

“in 2021, medical applications segment held dominant share.”

Based on application, the synthetic biology market is segmented into medical applications, industrial applications, food & agriculture, and environmental applications. The medical applications segment held domiant share in synthetic biology market . Adoption of synthetic biology in research and drug discovery & development is one of the major factor anticipated to project the market growth.

“Asia Pacific region is likely to grow at faster pace.”

The synthetic biology market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the dominant share in synthetic biology market. The dominance of the region is attributable to various factors such as presence of dominant and key market players in the region coupled augmented use of synthetic biology in various application. Asia Pacific region is likely to grow at faster pace owing to various factors such as rise in demand for synthetic cells across the region, increased research and development funding and emergence of new market players in the synthetic biology market.

The primary interviews conducted for this report can be categorized as follows:
•By Respondent: Supply Side- 60%, and Demand Side - 40%
•By Designation (Supply Side): Managers - 45%, CXOs & Directors - 25%, Executives- 15%, Other -15.0%
•By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%

Lists of Companies Profiled in the Report:
•Thermo Fisher Scientific (US)
•Merck KGaA (Germany)
•Agilent Technologies (US)
•Novozymes (Denmark)
•Ginkgo Bioworks (US)
•Amyris (US)
•Precigen (US)
•GenScript Biotech Corporation (China)
•Twist Bioscience (US)
•Synthetic Genomics (US)
•Codexis (US)
•Synthego (US)
•Creative Enzymes (US)
•Eurofins Scientific (Luxembourg)
•Cyrus Biotechnology (US)
•ATUM (US)
•TeselaGen (US)
•Arzeda (US)
•Integrated DNA Technologies (US)
•New England Biolabs (US)
•Elevate Bio (US)
•ZENFOLD (Iosynth) (India)
•Synbio Technologies (US)
•Inscripta, Inc. (US)
•CRISPR Therapeutics (Switzerland).

Research Coverage:
This report provides a detailed picture of the synthetic biology market. It aims at estimating the size and future growth potential of the market across different segments, such as tool, technology, application, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall synthetic biology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

Content
Table of Contents

1INTRODUCTION56
1.1STUDY OBJECTIVES56
1.2MARKET DEFINITION AND SCOPE56
1.2.1INCLUSIONS AND EXCLUSIONS56
1.2.2MARKETS COVERED57
1.2.3YEARS CONSIDERED58
1.3CURRENCY58
1.4STAKEHOLDERS58
1.5LIMITATIONS59
1.6SUMMARY OF CHANGES59
1.7RECESSION IMPACT60
2RESEARCH METHODOLOGY61
2.1RESEARCH APPROACH61
FIGURE 1RESEARCH DESIGN61
2.1.1SECONDARY DATA62
2.1.2PRIMARY RESEARCH63
FIGURE 2SYNTHETIC BIOLOGY MARKET: PRIMARY RESPONDENTS63
2.2MARKET ESTIMATION METHODOLOGY64
2.2.1AVERAGE MARKET SIZE ESTIMATION (2021)65
2.2.2REVENUE MAPPING-BASED MARKET ESTIMATION66
FIGURE 3MARKET SIZE ESTIMATION: REVENUE-BASED ESTIMATION METHODOLOGY66
2.3DATA TRIANGULATION67
FIGURE 4DATA TRIANGULATION METHODOLOGY67
2.4GROWTH RATE ASSUMPTIONS68
2.5GROWTH FORECAST68
FIGURE 5GROWTH RATE ANALYSIS FOR SYNTHETIC BIOLOGY MARKET68
2.6RISK ASSESSMENT68
2.7INSIGHTS FROM PRIMARY EXPERTS69
2.8RECESSION IMPACT69
TABLE 1GLOBAL INFLATION RATE PROJECTIONS, 2021–202769
3EXECUTIVE SUMMARY71
FIGURE 6SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022 VS. 2027 (USD MILLION)71
FIGURE 7SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)72
FIGURE 8SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)73
FIGURE 9REGIONAL SNAPSHOT OF SYNTHETIC BIOLOGY MARKET74
4PREMIUM INSIGHTS75
4.1SYNTHETIC BIOLOGY MARKET OVERVIEW75
FIGURE 10DIVERSE APPLICATIONS OF SYNTHETIC BIOLOGY TO DRIVE MARKET75
4.2NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION AND COUNTRY (2021)76
FIGURE 11US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SYNTHETIC BIOLOGY MARKET IN 202176
4.3SYNTHETIC BIOLOGY MARKET SHARE, BY APPLICATION, 202177
FIGURE 12MEDICAL APPLICATIONS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 202177
4.4SYNTHETIC BIOLOGY MARKET: REGIONAL GROWTH OPPORTUNITIES78
FIGURE 13ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD78
5MARKET OVERVIEW79
5.1INTRODUCTION79
5.2MARKET DYNAMICS79
FIGURE 14SYNTHETIC BIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES79
TABLE 2SYNTHETIC BIOLOGY MARKET: IMPACT ANALYSIS80
5.2.1DRIVERS80
5.2.1.1Diverse applications of synthetic biology80
5.2.1.2Increased funding for research in synthetic biology82
5.2.1.3Declining cost of DNA sequencing and synthesizing83
FIGURE 15REDUCTION IN COST PER RAW MEGABASE OF DNA SEQUENCING (USD), 2010–202083
5.2.1.4Innovations in synthetic biology83
5.2.2RESTRAINTS84
5.2.2.1Biosafety, biosecurity, and ethical concerns84
5.2.3OPPORTUNITIES85
5.2.3.1Increasing demand for fuel alternatives85
5.2.3.2Growth in research on synthetic drugs and vaccines86
TABLE 3CLINICAL TRIALS UTILIZING ANTIGENS OR BIOLOGICAL MATERIALS IN VACCINES86
5.2.3.3Use of machine learning in research and development87
5.2.4CHALLENGES87
5.2.4.1Standardization of biological parts87
5.3TECHNOLOGY ANALYSIS88
TABLE 4COMPARISON OF MODERN GENE EDITING TOOLS88
TABLE 5MACHINE LEARNING METHODS CURRENTLY APPLIED IN METABOLIC MODELS OF INDUSTRIAL MICROORGANISMS89
5.4ECOSYSTEM ANALYSIS90
FIGURE 16ECOSYSTEM ANALYSIS: SYNTHETIC BIOLOGY MARKET90
TABLE 6SYNTHETIC BIOLOGY MARKET: ROLE IN ECOSYSTEM90
5.5PATENT ANALYSIS92
5.6PRICING ANALYSIS93
TABLE 7AVERAGE SELLING PRICE OF SYNTHETIC BIOLOGY PRODUCTS (2021)93
TABLE 8SELLING PRICE OF VARIOUS PRODUCTS/SERVICES, BY KEY PLAYER93
5.7PORTER’S FIVE FORCES ANALYSIS94
TABLE 9SYNTHETIC BIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS94
5.7.1THREAT OF NEW ENTRANTS95
5.7.2THREAT OF SUBSTITUTES95
5.7.3BARGAINING POWER OF SUPPLIERS95
5.7.4BARGAINING POWER OF BUYERS95
5.7.5INTENSITY OF COMPETITIVE RIVALRY95
5.8VALUE CHAIN ANALYSIS96
FIGURE 17VALUE CHAIN ANALYSIS OF SYNTHETIC BIOLOGY MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE96
5.9REGULATORY ANALYSIS97
5.9.1REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES97
TABLE 10REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES98
5.9.2REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS98
TABLE 11NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS98
TABLE 12EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS99
TABLE 13ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS99
5.10KEY CONFERENCES AND EVENTS IN 2022–2023100
TABLE 14SYNTHETIC BIOLOGY MARKET: DETAILED LIST OF CONFERENCES AND EVENTS100
5.11KEY STAKEHOLDERS AND BUYING CRITERIA101
5.11.1KEY STAKEHOLDERS IN BUYING PROCESS101
FIGURE 18INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS101
TABLE 15INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS101
5.11.2BUYING CRITERIA102
FIGURE 19KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS102
5.12TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS102
6SYNTHETIC BIOLOGY MARKET, BY TOOL103
6.1INTRODUCTION104
TABLE 16SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)104
6.2OLIGONUCLEOTIDES AND SYNTHETIC DNA104
6.2.1INCREASING DEMAND FOR SYNTHETIC DNA TO SUPPORT MARKET GROWTH104
TABLE 17SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY REGION, 2020–2027 (USD MILLION)105
TABLE 18NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY COUNTRY, 2020–2027 (USD MILLION)106
TABLE 19EUROPE: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY COUNTRY, 2020–2027 (USD MILLION)106
TABLE 20ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY COUNTRY, 2020–2027 (USD MILLION)107
TABLE 21LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY COUNTRY, 2020–2027 (USD MILLION)107
6.3ENZYMES107
6.3.1LAUNCH OF NOVEL ENZYMES TO PROPEL MARKET107
TABLE 22SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY REGION, 2020–2027 (USD MILLION)108
TABLE 23NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION)109
TABLE 24EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION)109
TABLE 25ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION)110
TABLE 26LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION)110
6.4CLONING TECHNOLOGY KITS111
6.4.1NEED FOR CREATION OF ARTIFICIAL DNA AND ASSEMBLY TO DRIVE MARKET111
TABLE 27SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY REGION, 2020–2027 (USD MILLION)111
TABLE 28NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2020–2027 (USD MILLION)112
TABLE 29EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2020–2027 (USD MILLION)112
TABLE 30ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2020–2027 (USD MILLION)113
TABLE 31LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2020–2027 (USD MILLION)113
6.5SYNTHETIC CELLS113
6.5.1RISING DEMAND FOR SYNTHETIC CELLS TO SUPPORT MARKET GROWTH113
TABLE 32SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY REGION, 2020–2027 (USD MILLION)114
TABLE 33NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2020–2027 (USD MILLION)115
TABLE 34EUROPE: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2020–2027 (USD MILLION)115
TABLE 35ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2020–2027 (USD MILLION)116
TABLE 36LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2020–2027 (USD MILLION)116
 
6.6CHASSIS ORGANISMS117
6.6.1INCREASING DEMAND FOR FOSSIL FUELS TO PROPEL MARKET117
TABLE 37SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY REGION, 2020–2027 (USD MILLION)117
TABLE 38NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2020–2027 (USD MILLION)118
TABLE 39EUROPE: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2020–2027 (USD MILLION)118
TABLE 40ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2020–2027 (USD MILLION)119
TABLE 41LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2020–2027 (USD MILLION)119
6.7XENO NUCLEIC ACIDS120
6.7.1GROWING DEMAND FOR BREAKTHROUGH MEDICINES TO SUPPORT MARKET GROWTH120
TABLE 42SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY REGION, 2020–2027 (USD MILLION)120
TABLE 43NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2020–2027 (USD MILLION)121
TABLE 44EUROPE: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2020–2027 (USD MILLION)121
TABLE 45ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2020–2027 (USD MILLION)122
TABLE 46LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2020–2027 (USD MILLION)122
7SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY123
7.1INTRODUCTION124
TABLE 47SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)124
7.2GENE SYNTHESIS124
7.2.1GENE SYNTHESIS TO DOMINATE MARKET DURING FORECAST PERIOD124
TABLE 48SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY REGION, 2020–2027 (USD MILLION)126
TABLE 49NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION)126
TABLE 50EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION)127
TABLE 51ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION)127
TABLE 52LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION)128
7.3GENOME ENGINEERING128
7.3.1INCREASING DEMAND FOR SYNTHETIC DNA AND GENES TO DRIVE MARKET128
TABLE 53SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY REGION, 2020–2027 (USD MILLION)129
TABLE 54NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2020–2027 (USD MILLION)129
TABLE 55EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2020–2027 (USD MILLION)130
TABLE 56ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2020–2027 (USD MILLION)130
TABLE 57LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2020–2027 (USD MILLION)131
7.4SEQUENCING131
7.4.1NGS TECHNOLOGY REQUISITE FOR BIOLOGICAL RESEARCH131
TABLE 58SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY REGION, 2020–2027 (USD MILLION)132
TABLE 59NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2020–2027 (USD MILLION)132
TABLE 60EUROPE: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2020–2027 (USD MILLION)133
TABLE 61ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2020–2027 (USD MILLION)133
TABLE 62LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2020–2027 (USD MILLION)134
7.5BIOINFORMATICS134
7.5.1RISING NEED FOR DATA MANAGEMENT AND CURATION TO DRIVE ADOPTION OF BIOINFORMATICS TECHNOLOGIES134
TABLE 63SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY REGION, 2020–2027 (USD MILLION)135
TABLE 64NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2020–2027 (USD MILLION)135
TABLE 65EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2020–2027 (USD MILLION)136
TABLE 66ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2020–2027 (USD MILLION)136
TABLE 67LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2020–2027 (USD MILLION)137
7.6CLONING137
7.6.1CLONING AIDS IN BUILDING NEW GENETIC MODULES/PATHWAYS, ENABLING RAPID ADVANCES IN RESEARCH ACROSS INDUSTRIES137
TABLE 68SYNTHETIC BIOLOGY MARKET FOR CLONING, BY REGION, 2020–2027 (USD MILLION)138
TABLE 69NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2020–2027 (USD MILLION)138
TABLE 70EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2020–2027 (USD MILLION)139
TABLE 71ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2020–2027 (USD MILLION)139
TABLE 72LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2020–2027 (USD MILLION)140
7.7SITE-DIRECTED MUTAGENESIS140
7.7.1WIDE APPLICATIONS IN GENETIC ENGINEERING, DNA ASSEMBLY, AND CLONING TECHNOLOGIES TO DRIVE MARKET140
TABLE 73SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY REGION, 2020–2027 (USD MILLION)141
TABLE 74NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2020–2027 (USD MILLION)141
TABLE 75EUROPE: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2020–2027 (USD MILLION)142
TABLE 76ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2020–2027 (USD MILLION)142
TABLE 77LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2020–2027 (USD MILLION)143
7.8MEASUREMENT AND MODELING143
7.8.1CELL-FREE SYNTHETIC BIOLOGY EMERGING AS POWERFUL TECHNOLOGY143
TABLE 78SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING, BY REGION, 2020–2027 (USD MILLION)144
TABLE 79NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING, BY COUNTRY, 2020–2027 (USD MILLION)144
TABLE 80EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING, BY COUNTRY, 2020–2027 (USD MILLION)145
TABLE 81ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING, BY COUNTRY, 2020–2027 (USD MILLION)145
TABLE 82LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING, BY COUNTRY, 2020–2027 (USD MILLION)146
7.9MICROFLUIDICS146
7.9.1DROPLET MICROFLUIDICS GAINING WIDE RECOGNITION IN FIELD OF SYNTHETIC BIOLOGY146
TABLE 83SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY REGION, 2020–2027 (USD MILLION)147
TABLE 84NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2020–2027 (USD MILLION)147
TABLE 85EUROPE: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2020–2027 (USD MILLION)148
TABLE 86ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2020–2027 (USD MILLION)148
TABLE 87LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2020–2027 (USD MILLION)149
7.10NANOTECHNOLOGY149
7.10.1CONVERGENCE BETWEEN SYNTHETIC BIOLOGY AND NANOTECHNOLOGY AIDS IN BUILDING COMPLEX BODIES149
TABLE 88SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY REGION, 2020–2027 (USD MILLION)150
TABLE 89NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)150
TABLE 90EUROPE: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)151
TABLE 91ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)151
TABLE 92LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)152
 
8SYNTHETIC BIOLOGY MARKET, BY APPLICATION153
8.1INTRODUCTION154
TABLE 93SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)154
8.2MEDICAL APPLICATIONS154
TABLE 94SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)155
TABLE 95SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)155
TABLE 96NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)156
TABLE 97EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2020–2027(USD MILLION)156
TABLE 98ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)157
TABLE 99LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)157
8.2.1PHARMACEUTICALS157
8.2.1.1Largest synthetic biology market for medical applications157
TABLE 100SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY REGION, 2020–2027 (USD MILLION)158
TABLE 101NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2020–2027 (USD MILLION)159
TABLE 102EUROPE: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2020–2027 (USD MILLION)159
TABLE 103ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2020–2027 (USD MILLION)160
TABLE 104LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2020–2027 (USD MILLION)160
8.2.2DRUG DISCOVERY AND THERAPEUTICS160
TABLE 105SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION)161
TABLE 106SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY REGION, 2020–2027 (USD MILLION)161
TABLE 107NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 2020–2027 (USD MILLION)162
TABLE 108EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 2020–2027 (USD MILLION)162
TABLE 109ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 2020–2027 (USD MILLION)163
TABLE 110LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 2020–2027 (USD MILLION)163
8.2.2.1Cancer detection and diagnostics163
8.2.2.1.1Increasing investments in cancer research to support market163
TABLE 111SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)164
TABLE 112NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)165
TABLE 113EUROPE: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)165
TABLE 114ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)166
TABLE 115LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)166
8.2.2.2Other drug discovery and therapeutic applications166
TABLE 116SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)167
TABLE 117NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)167
TABLE 118EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)168
TABLE 119ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)168
TABLE 120LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)169
8.2.3ARTIFICIAL TISSUE AND TISSUE REGENERATION169
TABLE 121SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)170
TABLE 122SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY REGION, 2020–2027 (USD MILLION)170
TABLE 123NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY COUNTRY, 2020–2027 (USD MILLION)171
TABLE 124EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY COUNTRY, 2020–2027 (USD MILLION)171
TABLE 125ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY COUNTRY, 2020–2027 (USD MILLION)172
TABLE 126LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY COUNTRY, 2020–2027 (USD MILLION)172
8.2.3.1Biosynthesis172
8.2.3.1.1Largest market due to increasing need to create artificial genomes172
TABLE 127SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY REGION, 2020–2027 (USD MILLION)173
TABLE 128NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION)173
TABLE 129EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION)174
TABLE 130ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION)174
TABLE 131LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION)175
8.2.3.2Stem cell regulation175
8.2.3.2.1Increased use of synthetic biology in stem cell regeneration and reprogramming somatic cells to drive market175
 
TABLE 132SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY REGION, 2020–2027 (USD MILLION)176
TABLE 133NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2020–2027 (USD MILLION)176
TABLE 134EUROPE: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2020–2027 (USD MILLION)177
TABLE 135ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2020–2027 (USD MILLION)177
TABLE 136LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2020–2027 (USD MILLION)178
8.2.3.3Other artificial tissue and tissue regeneration applications178
TABLE 137SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)179
TABLE 138NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)179
TABLE 139EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)180
TABLE 140ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)180
TABLE 141LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)181
8.3INDUSTRIAL APPLICATIONS181
TABLE 142SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)182
TABLE 143SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)182
TABLE 144NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)183
TABLE 145EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)183
TABLE 146ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)184
TABLE 147LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)184
8.3.1BIOFUEL AND RENEWABLE ENERGY184
8.3.1.1Advantages of using genetically engineered organisms for synthetic production of biofuels to support market184
TABLE 148SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY REGION, 2020–2027 (USD MILLION)185
TABLE 149NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 2020–2027 (USD MILLION)186
TABLE 150EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 2020–2027 (USD MILLION)186
TABLE 151ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 2020–2027 (USD MILLION)187
TABLE 152LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 2020–2027 (USD MILLION)187
8.3.2INDUSTRIAL ENZYMES187
TABLE 153SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION)188
TABLE 154SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY REGION, 2020–2027 (USD MILLION)189
TABLE 155NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION)189
TABLE 156EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION)190
TABLE 157ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION)190
TABLE 158LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION)191
8.3.2.1Textile industry191
8.3.2.1.1Synthetic biology to replace traditional raw materials in textile industry191
TABLE 159SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY REGION, 2020–2027 (USD MILLION)192
TABLE 160NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)192
TABLE 161EUROPE: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)193
TABLE 162ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)193
TABLE 163LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)194
8.3.2.2Paper industry194
8.3.2.2.1Increasing use of enzymes in pulp and paper industry to favor market growth194
TABLE 164SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY REGION, 2020–2027 (USD MILLION)195
TABLE 165NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)195
TABLE 166EUROPE: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)196
TABLE 167ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)196
TABLE 168LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)197
8.3.2.3Consumer care industry197
TABLE 169SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION)197
TABLE 170SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY REGION, 2020–2027 (USD MILLION)198
TABLE 171NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)198
TABLE 172EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)199
TABLE 173ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)199
TABLE 174LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)200
8.3.2.3.1Cosmetics200
8.3.2.3.1.1Increased use of synthetic biology techniques for development of skincare and cosmetics to propel market200
TABLE 175SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS, BY REGION, 2020–2027 (USD MILLION)201
TABLE 176NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS, BY COUNTRY, 2020–2027 (USD MILLION)201
TABLE 177EUROPE: SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS, BY COUNTRY, 2020–2027 (USD MILLION)202
TABLE 178ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS, BY COUNTRY, 2020–2027 (USD MILLION)202
TABLE 179LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS, BY COUNTRY, 2020–2027 (USD MILLION)203
8.3.2.3.2Other consumer care products203
TABLE 180SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY REGION, 2020–2027 (USD MILLION)204
TABLE 181NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)204
TABLE 182EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)205
TABLE 183ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)205
TABLE 184LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)206
8.3.2.4Other industries206
TABLE 185SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY REGION, 2020–2027 (USD MILLION)207
TABLE 186NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2020–2027 (USD MILLION)207
TABLE 187EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2020–2027 (USD MILLION)208
TABLE 188ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2020–2027 (USD MILLION)208
TABLE 189LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2020–2027 (USD MILLION)209
8.3.3BIOMATERIALS AND GREEN CHEMICALS209
8.3.3.1Use of synthetic biology for preparing silk-based proteins to support market209
TABLE 190SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY REGION, 2020–2027 (USD MILLION)210
TABLE 191NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)210
TABLE 192EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)211
TABLE 193ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)211
TABLE 194LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)212
8.4FOOD AND AGRICULTURAL APPLICATIONS212
TABLE 195SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)213
TABLE 196SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)213
TABLE 197NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)214
TABLE 198EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)214
TABLE 199ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)215
TABLE 200LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)215
8.4.1FLAVORS AND FRAGRANCES215
8.4.1.1Manufactured using engineered microbes215
TABLE 201SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES, BY REGION, 2020–2027 (USD MILLION)216
TABLE 202NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES, BY COUNTRY, 2020–2027 (USD MILLION)216
TABLE 203EUROPE: SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES, BY COUNTRY, 2020–2027 (USD MILLION)217
TABLE 204ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES, BY COUNTRY, 2020–2027 (USD MILLION)217
TABLE 205LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES, BY COUNTRY, 2020–2027 (USD MILLION)218
8.4.2OTHER FOOD AND AGRICULTURAL APPLICATIONS218
TABLE 206SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)219
TABLE 207NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)219
TABLE 208EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)220
TABLE 209ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)220
TABLE 210LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)221
8.5ENVIRONMENTAL APPLICATIONS221
TABLE 211SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)222
TABLE 212SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)222
TABLE 213NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)223
TABLE 214EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)223
TABLE 215ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)224
TABLE 216LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)224
8.5.1BIOREMEDIATION224
8.5.1.1Bioremediation helps in cleaning oil spills, preventing chemical pollution, and plugging nuclear leakages224
TABLE 217SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY REGION, 2020–2027 (USD MILLION)225
TABLE 218NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2020–2027 (USD MILLION)225
TABLE 219EUROPE: SYNTHETIC BIOLOGY MARKET FOR